RecruitingNCT04032470
Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
Boston Scientific Registry of Deep Brain Stimulations for Treatment of Essential Tremor (ET):ET Registry
Sponsor
Boston Scientific Corporation
Enrollment
500 participants
Start Date
Oct 23, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
To compile characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Deep Brain Stimulation (DBS) Systems, when used according to the applicable Directions for Use, for the treatment of Essential Tremor.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Meets criteria established in the locally applicable Directions for Use (DFU) for Essential Tremor
- Is at least 18 years old
Exclusion Criteria1
- Meets any contraindication in locally applicable Directions for Use
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEDeep Brain Stimulation Systems (DBS)
Subjects receiving DBS implant for treatment of Essential Tremor
Locations(20)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04032470
Related Trials
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
NCT0366460919 locations
Deep Brain Stimulation Surgery for Movement Disorders
NCT015815801 location
EMBRACE Tremor BiFUS
NCT069749166 locations
Cortical-Basal Ganglia Speech Networks
NCT042863081 location
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
NCT065536254 locations